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Highly efficient and specific biomolecular recognition requires both affinity and specificity. Previous
quantitative descriptions of biomolecular recognition were mostly driven by improving the affinity
prediction, but lack of quantification of specificity. We developed a novel method SPA (SPecificity and
Affinity) based on our funneled energy landscape theory. The strategy is to simultaneously optimize the
quantified specificity of the ‘‘native’’ protein-ligand complex discriminating against ‘‘non-native’’ binding
modes and the affinity prediction. The benchmark testing of SPA shows the best performance against 16
other popular scoring functions in industry and academia on both prediction of binding affinity and
‘‘native’’ binding pose. For the target COX-2 of nonsteroidal anti-inflammatory drugs, SPA successfully
discriminates the drugs from the diversity set, and the selective drugs from non-selective drugs. The
remarkable performance demonstrates that SPA has significant potential applications in identifying lead
compounds for drug discovery.
B
iomolecular recognition is central to cellular processes mediated by the formation of complexes between
biomolecular receptors and their ligands. Understanding of biomolecular recognition is one of the most
importantissuesinmodernmolecularbiology
1,2andhasdirectapplicationsindrugdiscoveryanddesign
3,4.
The fast and accurate prediction of a ligand specifically binding to a target protein is a crucial step for lead
discovery. During the past two decades, considerable efforts have been devoted to the development of docking
algorithms and scoring functions
5. There are many docking algorithms available, however, imperfections of
scoring functions continue to be a major limiting factor
6,7.
Highly efficient and specific biomolecular recognition requires both affinity and specificity
8–11. The stability of
the complex is determined by the affinity while the specificity is controlled by either partner binding to other
competitive biomolecules discriminatively. The current scoring functions of protein-ligand binding
12, whether
force-fieldbased,empirical,orknowledge-basedscoringfunctions,aremainlyfocusedonimprovingtheabilityof
predicting the known binding affinities observed in experiments as accurately as possible. The strategy of
developing these scoring functions seeks to optimize the stability based on the combination of energetics and
shape complementarity without explicit consideration of binding specificity.
However, high affinity does not guarantee high specificity which is critical for function, e.g. drug-target
recognition. To design a drug, one has to design a lead compound binding to a specific target receptor rather
than others indiscriminately for avoiding the possible side effects. According to the Boltzman distribution (P ,
exp[2F/KT]), the equilibrium population is exponentially dependent on the binding free energy. A gap in
binding free energy or affinity will lead to significant population discrimination between the specific complex
and non-specific ones. Thus to develop a scoring function, the strategy should satisfy the requirement that the
stabilityofthespecificcomplexismaximizedwhilethestabilityofcompetingcomplexesisminimized,whichcan
guarantee both the stability and the specificity for the specific complex.
The reason that the specificity usually was not taken into account explicitly is that the description of binding
specificity waschallengingtoquantify. Theconventionaldefinition(Fig. 1a)ofspecificity istheabilityofaligand
to specifically bind to a protein against other proteins, namely the relative difference in affinity of one specific
protein-ligandcomplextoothers
8–11.Thequantificationofconventionalspecificityischallengingsincespecificity
requires comparison of the affinities of all the different receptors with the same ligand. The receptor universe is
hugeandtheinformationisoftenincompleteonthoseproteins.Weproposedanalternativewaytoquantitatively
SUBJECT AREAS:
BIOPHYSICS
COMPUTATIONAL BIOLOGY
BIOLOGICAL SCIENCES
BIOINFORMATICS
Received
24 January 2012
Accepted
9 February 2012
Published
12 March 2012
Correspondence and
requests for materials
should be addressed to
J.W. (jin.wang.1@
stonybrook.edu)
SCIENTIFIC REPORTS | 2 : 309 | DOI: 10.1038/srep00309 1determine the ligand-receptor binding specificity
13,14.T h en e wv i e wo f
specificity is that a specific and native binding site of a ligand to its
receptor is preferred to other binding sites on the same receptor (Fig.
1b). This concept is based on the assumption that a ligand binding to
many protein receptors is equivalent to its bindingto them with N and
C terminus of these protein receptors linked together, leading to bind-
ing to an effectively large protein. Therefore, if the target protein is
large enough, one can think of it as composed of many different
segments each mimicking a protein receptor. The conventional spe-
cificity as relative affinity against different receptors now becomes
specificity of the native binding mode againstthe other binding modes
f o rt h i sl a r g et a r g e tp r o t e i n( F i g .1 a , b ) .
Also, one receptor protein with different sites binding with a
ligand is similar to the case of the whole universe of different ligands
binding with the same receptor (Fig. 1c). If the protein target size is
large enough, then the spatial contact interactions can be sampled
enough to cover all the contact interactions appeared in the ligand
bindingtodifferentreceptors.Arecentworkonmoleculardynamics
of a ligand searching for binding to the receptor has validated this
assumption. In that work, Shaw et al.
15 carried out a relatively long
molecular dynamics simulation in which the inhibitor PP1 was ini-
tially placed at a random location to search the docking sites on the
protein Src kinase. Persistent and noteworthy intermediate confor-
mations with the inhibitor located diversely on the surface of the
kinase were observed in the binding process, indicating multiple
competing binding sites do exist on the same receptor.
Similar to protein folding, the binding process of protein-ligand
can be physically quantified and visualized as a funnel-like energy
landscape towards the native binding state with local roughness
along the binding paths
13,14,16–23. According to the theory of energy
landscape(Fig.2),thenativeconformationofthebindingcomplexis
the conformation with the lowest binding energy and the energies of
the non-native conformations follow a statistical Gaussian distri-
bution. A dimensionless quantity dE
DE ﬃﬃﬃﬃ
2S
p (termed as intrinsic specifi-
city ratio (ISR), where dE is the energy gap between the native
binding state and the average non-native binding states, DE is the
energy variance of the non-native states and S is the configurational
entropy) is defined to describe the magnitude of intrinsic specificity.
A large ISR indicates a high level of discrimination of the native
binding state from the non-native binding states, which means a
high specificity. Therefore, ISR provides a quantitative measure of
intrinsic specificity that can be determined without evaluating the
conventional specificity by exploring the whole set of receptor or
ligand universe.
Giventheinherentlimitationsofcurrentscoringfunctionsandthe
demandsforthepracticalwayofevaluatingspecificity,wedeveloped
a novel scoring function by optimizing both intrinsic specificity
and affinity in this study (named as SPA, SPA stands for
SPecificityandAffinity.ThedevelopmentflowchartofSPAisshown
in Supplementary Fig. 1). The optimizing strategy for SPA is to
simultaneously reachthe maximization of the performances onboth
thespecificityandtheaffinitypredictionsofthetrainingset.SPAwas
validated by testing the benchmark set and the performance was
compared with 16 previous scoring functions. The test results
showed that SPA outperformed all these previous scoring functions.
SPA was also applied for a target protein cyclooxygenase-2 (COX-2)
of nonsteroidal anti-inflammatory drugs (NSAIDs) for discrimina-
tion of the drugs against the diversity set, and selective drugs against
non-selective drugs. The results suggested that more reliable lead
compounds can be screened with SPA through two dimensional
screening of intrinsic specificity ISR and affinity.
Results
Binding pose prediction. The process of a ligand binding to a
protein can be thought as a conformational search guided by a
scoring function, and the final destination is to look for the
‘‘native’’ binding pose with the best score. Whether the scoring
function can select out the best-scored binding pose which
resembles the one in the crystal structure closely determines the
performance of the scoring function for identifying the ‘‘native’’
binding conformation. Normally, the root mean square deviation
(RMSD) is taken as the measure of the structural closeness
Figure 1 | Illustration of the equivalence of conventional specificity to
intrinsic specificity. (a) Different receptors (green) binding to the same
ligand (red) with the corresponding energy spectrum. (b) Different
binding states (modes) of a particular ligand to its receptor. (c) Different
ligands binding to the same receptor.
Figure 2 | Distribution of energy and funneled energy landscape of the biomolecular binding. (a) Multiple docking complex conformations ofCOX-2
with a selective drug (SC-558), the native pose of the drug shown in red and sticks while other decoys shown in blue and lines. (b) The binding energy
spectrum for different binding decoys. (c) The corresponding distribution of binding energies where the standard deviation of energy (DE), average
energy of decoys (, ED .) and the energy gap (dE) are represented. (d) Energy landscape of binding with a funneled shape towards the native state.
www.nature.com/scientificreports
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conformation which is the ligand pose in the crystal structure here.
If the RMSD value of the best-scored binding pose is less than a
predefined cutoff, it is considered as a successful recognition of the
‘‘native’’ or ‘‘near-native’’ binding pose by the scoring function.
To make a comparison with other scoring functions, the success
rateforthebenchmarksetwascalculatedbySPAandcomparedto16
scoring functions implemented in the mainstream commercial soft-
wares or available from academic research groups
24 (Table 1). The
success rates of SPA as well as the other 16 scoring functions under
five different cutoffs (1.0, 1.5, 2.0, 2.5 and 3.0 A ˚) clearly shows that
SPA performs the best among all the scoring functions no matter
what criterion of RMSD cutoff is used, suggesting that SPA is very
successfulontheabilitytoidentify‘‘native’’or‘‘near-native’’binding
poses.
In practice, besides the best-scored binding pose, multiple other
binding poses with good scores can also be selected out as putative
‘‘native’’ binding poses. Namely, it is probable in molecular docking
to select a few binding poses with top-ranked scores for further
evaluation in hierarchical database screenings
25. The success rates
were compared for the binding poses with top five scores under
the commonly used criterion of RMSD cutoff (52.0 A ˚)
(Supplementary Table 1). We can see that SPA yields more than
90% success rate to identify the ‘‘native’’ binding pose when the
binding scores are considered from top two to five binding scores.
It has comparable performance as other three top-ranked scoring
function GOLD/ASP, DrugScorePDB/PairSurf and DS/PLP1. This
result further validates the outstanding performance of SPA on the
‘‘native’’ or ‘‘near-native’’ binding pose identification.
A high success rate of identifying the ‘‘native’’ conformation
implies that the binding poses structurally close to the ‘‘native’’ con-
formation have high binding scores in energetics. This structure-
energy correlation is consistent with the concept of funnel-shaped
energy landscape of protein-ligand binding
13, where the ‘‘native’’
binding conformation with lowest energy locates at the global min-
imum ofthe energy landscape and the conformations with low ener-
gies are structurally similar to the ‘‘native’’ conformation. According
to the energy landscape theory
16,17, it is promising that SPA with the
highest success rate to identify the ‘‘native’’ conformation can search
the global minimum with a fast convergence if it is applied to guide
theconformationalsamplinginmoleculardocking.Thehighsuccess
rate also implies the capability of SPA to discriminate the ‘‘native’’
binding mode against decoys. This leads to a better quantification
anddiscrimination ofintrinsicspecificityandthereforethe(conven-
tional) specificity of biomolecular recognition.
Bindingaffinityprediction.Inadditiontothepredictionofbinding
pose,thepredictionofbindingaffinityisanotherimportantcriterion
to evaluate the performance of scoring function. In contrast to
binding pose prediction which emphasizes on the discrimination
of the ‘‘native’’ conformation from the ‘‘non-native’’ decoys for
each protein-ligand complex, the prediction of binding affinity
relates to the ability of reproducing the experimentally measured
binding affinities for different types of protein-ligand complexes. It
determines the accuracy of binding scores predicted by the scoring
functions compared with the experimental measurements. Due to
scaling, the scoring functions usually cannot reproduce the absolute
valuesof experimental bindingaffinities, the correlation between the
predicted and experimental measured binding affinities is widely
used to evaluate the accuracy of binding affinity prediction. Pear-
son correlation coefficients (CP) and Spearman rank correlation coef-
ficients (CS) between the binding scores and the known binding
constants were computed.
Itcanbeseen(Table2)thatSPAgivesthebestcorrelationsofboth
CPandCS.Comparedtootherscoringfunctions,thisperformanceof
SPA is surprisingly good since no other scoring functions simulta-
neously rank on the tops for both the predictions of binding pose
(Table 1) and binding affinity (Table 2). For example, X-Score/
HMScore performs well on the prediction of binding affinity but
moderately on the prediction of binding pose. GOLD/ASP is able
toidentifythecorrectbindingposewithasecondhighestsuccessrate
whereas it is less successful to reproduce the binding affinities. It is
worthnoticingthatonlySPAandX-Score/HMScoreachieveCPover
0.6 in predicting affinity which is much superior to other scoring
functions (Supplementary Fig. 2).
The best performance of SPA on the prediction of both binding
pose and binding affinity suggests that the optimization strategy
calibrated to improve specificity and affinity for the development
of SPA is the correct route to explore the protein-ligand recognition.
SPA is not only capable of discriminating the specific ‘‘native’’ con-
formation out of a large number of decoys by their scores but also
accurately predicting the binding affinities of different protein-
ligand complexes. This result is encouraging and motivates us to
apply SPA in the virtual screening to identify the lead compounds
for drug discovery with both affinity and specificity.
Table 1 | Successratesofidentifyingthe‘‘native’’or‘‘near-native’’
conformations under different RMSD cutoffs
Scoring Function
a 1.0A ˚ 1.5A ˚ 2.0A ˚ 2.5A ˚ 3.0A ˚
SPA 78.5 83.1 84.7 87.6 93.2
GOLD/ASP 69.3 79.2 82.5 85.2 89.1
DS/PLP1 65.0 72.1 75.4 78.7 84.2
DrugScore
PDB/PairSurf 62.8 69.4 74.3 77.6 81.4
GlideScore/SP 54.6 64.5 73.2 76.0 84.7
DS/LigScore2 54.1 62.8 71.6 75.4 80.3
GOLD/ChemScore 54.6 62.8 70.5 71.6 79.2
GOLD/GoldScore 51.9 61.2 68.9 72.1 80.9
X-Score1.2/HMScore 51.4 59.6 68.3 72.1 78.1
SYBYL/F-Score 54.6 61.7 64.5 68.3 73.8
SYBYL/ChemScore 40.4 49.7 60.1 65.6 71.6
DS/Ludi2 41.5 48.6 57.4 61.7 67.2
SYBYL/PMF-Score 37.2 41.5 48.1 53.0 56.8
DS/Jain 25.7 36.1 44.8 54.6 64.5
DS/PMF 32.2 36.1 43.7 47.5 53.6
SYBYL/G-Score 25.1 35.5 41.5 48.6 56.3
SYBYL/D-Score 15.3 23.5 30.6 39.3 47.5
aThe results except SPA are obtained from the literature
24.
Table 2 | Correlations between the predicted binding affinity and
experimentally measured binding affinity
Scoring Function
a CP CS
SPA 0.668 0.733
X-Score/HMScore 0.644 0.705
DrugScore
CSD/PairSurf 0.569 0.627
SYBYL/ChemScore 0.555 0.585
DS/PLP1 0.545 0.588
GOLD/ASP 0.534 0.577
SYBYL/G-Score 0.492 0.536
DS/Ludi3 0.487 0.478
DS/LigScore2 0.464 0.507
GlideScore/XP 0.457 0.432
DS/PMF 0.445 0.448
GOLD/ChemScore 0.441 0.452
NHA 0.431 0.517
SYBYL/D-Score 0.392 0.447
DS/Jain 0.316 0.346
GOLD/GoldScore 0.295 0.322
SYBYL/PMF-Score 0.268 0.273
SYBYL/F-Score 0.216 0.243
aThe results except SPA are obtained from the literature
24.
www.nature.com/scientificreports
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the benchmark test, we want to evaluate the ability of SPA in real
virtual screening test. The enzyme cyclooxygenase-2 (COX-2) was
chosenasourtargetproteinmodelwhichisthetargetofnonsteroidal
anti-inflammatory drugs (NSAIDs) for reducing fever and in-
flammation, such as the commonly-taken drugs aspirin, motrin,
telenoid, and advil. The virtual screening for COX-2 is challenging.
Besides the importance to discriminate the drugs from the diversity
set, it is more important to distinguish selective and nonselective
drugs since selective drugs is more potent to inhibit COX-2 than
non-selectivedrugs.Whetherthedifferences canbeevaluatedaccor-
ding to the affinities and specificities determines the performance of
SPA in the applications of virtual screening.
As seen from the enrichment curves (Fig. 3a), the selective drugs
areobviouslyseparatedfromthediversityset,whilethenon-selective
drugs are weakly separated from the diversity set. This indicates that
SPAhasthecapacityto discriminate the drugsfromthediversity set,
especially the selective drugs from the diversity set. The weak dis-
crimination of non-selective drugs from the diversity set may result
from the fact that the non-selective drugs are not specific for COX-2
and have much lower potency than the selective drugs. Clearly, the
statistics of the top-ranked compounds of all the ligands (Sup-
plementaryTable2),oftentakenasinterestcompoundsinthevirtual
screening, shows that compared to affinity, the specificity is a more
efficient criterion to select the drugs out of the top-ranked
compounds. Itis worth noticing thatthe performance of linearcom-
bination of the affinity and specificity is better than the single para-
meter to discriminate the selective drugs from the diversity set.
To further quantify the discrimination of selective drugs from
non-selective drugs, the statistical discrimination KS test was calcu-
lated (Fig. 3b). The relative high values of KS statistic (higher than
40%) suggest significant differences between the selective drugs and
the non-selective drugs in both affinity and specificity, and more
obvious in terms of the combination of them. The KS statistic results
demonstrate that SPA is capable to discriminate selective drugs
against non-selective drugs, which is important for selecting drug
candidates with specificity against targets such as COX-2.
Based on the performance of SPA on the screening, a two-dimen-
sional projection of specificity and affinity is plotted (Fig. 3c) for
COX-2 with the diversity set of 650 selected compounds as well as
its 37 selective and 20 non-selective drugs. The basin center with the
highest density locates in the area with small ISR and low affinity,
indicating that random compounds which have weak thermodyn-
amic stability also generally do not have high specificity. Whereas,
mostoftheselectivedrugshavelargeISRandhighaffinity,andmost
of the non-selective market drugs tend to have relatively smaller ISR
and lower affinity. It is worth noticing that a few drugs have values
near the basin center in one parameter (ISR or affinity), but have
larger values in another parameter, which suggests that specificity
and affinity can be complementary in searching some specific drug
candidates in virtual screening. These results validate that specificity
is an important property of drug-target system.
These results validate that specificity is an important property of
drug-target system. Previously, both experimentally and computa-
tionally screening techniques mostly concentrated on the affinity
selection for the lead compounds. The virtual screening test of SPA
here demonstrates that the ISR is an appropriate indicator for the
lead compounds with specificity selection. Experimentally, it is chal-
lenging to determine the binding specificity for a given target.
Computationally, it is practical to employ the scoring functions to
carry out two dimensional virtual screening using both affinity and
ISR in drug discovery. SPA is a good choice based on its excellent
performance.
Discussion
In this work, we developed a novel and quantitative descriptions of
biomolecular interactions through the scoring function called SPA
which takes into account of both specificity and affinity of protein-
ligand binding. It represents a significant advance over the previous
investigations on protein-ligand binding interactions and scoring
functionsthatonlyfocusedonaffinityfordevelopment.Twoanother
important innovations are incorporated into SPA. Firstly, SPA pro-
vides an effective way to circumvent the calculation of the reference
state which is an issue in the development of knowledge-based scor-
ing functions
26–28. Secondly, lacking of a large and high-quality set of
protein-ligand complexes with experimentally determined binding
affinitiesandthreedimensionalstructureswasabottleneckfordevel-
oping accurate and general scoring functions. SPA takes the largest
data so far of high-quality set of protein-ligand complexes with
experimentally determined binding affinities and 3D structures
29.
It gives SPA with the chance to be less training-set dependent and
more general for applications, which is superior than previous
empirical scoring functions.
The excellent performance of SPA was validated by the test on a
benchmark set. Compared to the other 16 existing popular scoring
functions,SPAachievesthehighestsuccessrateinidentifyingcorrect
binding pose, yields the highest correlation coefficient in the predic-
tion of the experimentally measured binding affinity. These signifi-
cantimprovements ofperformances over previous scoringfunctions
areveryencouragingandmotivateustoapplySPAinidentifyingthe
lead compounds in drug discovery. The virtual screening test of SPA
Figure 3 | Statistics for the drugs and two dimensional contour map of
drugscreening. (a)Enrichment forboth selectiveandnon-selective drugs
with E, ISR and the linear combination of them (E & ISR) through logistic
regression (b) KS statistic for the discrimination of selective drugs and
non-selective drugs by the difference of cumulative fraction based on the
parameters. (c) Two dimensional density contour map of binding affinity
and ISR for 650 small molecules binding with COX-2, the selective drugs
shown in red and non-selective drugs shown in green.
www.nature.com/scientificreports
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onlythedrugsfromthediversitysetaccordingtothebindingaffinity
aswellas thespecificity, butalsotheselective drugsfromnon-select-
ive drugs, the later discrimination is more demanding in the discov-
ery of lead compounds for drug targets. Thus, more reliable lead
compounds with both stability and specificity can be searched with
SPA scoring. The success of SPA proves that the specificity is critical
to the biomolecular recognition and necessary to be incorporated to
the scoring function. In the computational design of the protein-
protein interactions
9,10, both stability and specificity can be consid-
ered to design the interactions for discriminating natural binding
partners from many other possible ones with similar sequences
and structures. In natural systems, both parameters may be subject
to evolutionary optimization, giving the rationality of the optimiza-
tion on affinity and specificity.
With the availability of rapidly increasing number of protein struc-
tures and the advent of high-performance computing system, compu-
tational virtual screening offers an effective and practical route to
discovering new drug molecules, a complementary or even an alterna-
tive way of experimental high-throughput screening
30.Intheprocesses
of virtual screening, the performance of the scoring function has a
major impact on the quality of molecular docking predictions. The
outstandingperformanceofSPAshowninthisworkmakesitpractical
to be implemented in the docking software and widely applied in
virtual screening for identifying the lead compounds.
Methods
Derivation of distance-dependent potentials. The initial atom-pair potential to be
optimized is directly derived from the Boltzmann relation widely used in the
knowledge-based statistical potentials
27,28,31, which is
uij r ðÞ ~{KBT lngij r ðÞ ð 1Þ
where gij(r) is the observed pair distribution function which can be calculated by
gij r ðÞ ~
f obs
ij r ðÞ
f
ref
ij R ðÞ ð2Þ
f obs
ij r ðÞ istheobserved numberdensityofatompair ijwithinasphericalshellbetween
r and r1dr and the f
ref
ij R ðÞ is the expected number density within the sphere of the
reference state where there were no interactions between atoms. The former can be
directly extracted from the database of protein-ligand complexes, while the later is
obtained based on the approximation that the atom pair ij is uniformly distributed in
the sphere of the reference state
32. Respectively, they are calculated as
f obs
ij r ðÞ ~ 1
M
P M
m
nm
ij r ðÞ
Vr ðÞ ð3Þ
f
ref
ij R ðÞ ~ 1
M
P M
m
Nm
ij
VR ðÞ ð4Þ
where M is the number of protein-ligand complexes, nm
ij r ðÞand Nm
ij are the numbers
of atom pair ij within the spherical shell and the reference sphere for a given protein-
ligand complex m, where Nm
ij ~
P
rnm
ij r ðÞ . Vr ðÞ ~ 4
3p rzDr ðÞ
3{r3   
and
VR ðÞ ~ 4
3pR3 arethevolumesofthesphericalshellandthereferencesphere,whereDr
is the bin size and R is the radius of sphere. In this work, Dr and R are set as 0.3A ˚ and
7.0A ˚, respectively. In total, there are 16 spherical shells with bin size 0.3 A ˚ from the
shortest radius 2.2A ˚ which is the value to exclude the protein-ligand complexes with
the steric atom clashes in PDBbind database
29.
In fact, the initial potential can be extracted from any database of protein-ligand
complex structures, while a good set of initial potentials can make optimizing search
more efficient. The database of protein-ligand complexes used here was taken from
the refined set of 2011 version in PDBbind database
29,33. This database provides a
comprehensive and highquality collection of the experimentally determined bio-
molecular complexes with measured binding affinities which were filtered from the
Protein Data Bank (PDB) by applying a series of criteria. Due to infrequent occur-
rence of metal atoms in the protein-ligand complexes, the complexes containing
metal atoms are excluded and only the potentials between nonmetal atoms are
considered. 2316 protein-ligand complexes are remaining as our database to extract
the initial potentials. Based on the definition of atom type by SYBYL
34, 22 atom types
are used to cover protein-ligand interactions (Supplementary Table. 3), these atom
types were converted from PDB files by BABEL
35. A cutoff (5600) of Nij was
employedtoignorethecontributionfromtheatompairswithstatisticallyinsufficient
occurrences. This leads to 101 effective types of atom pairs in our calculation. In
addition, if the atom pair has no occurrence in a particular spherical shell, the cor-
responding pair potential was set as the van der Waals interaction within this shell.
Generation of docking decoys. To calculate the ISR for the optimization of SPA,
enough conformations need to be sampled for each ligand docking to its specific
protein receptor to explore the underlying binding energy landscape
13,14. For each
protein-ligand complex, except the ‘‘native’’ protein-ligand conformation obtained
from the PDB structure, all the conformational decoys of protein-ligand complexes
were generated by the molecular docking with software AutoDock4.2
36 in this work.
Given that enough sampling of binding decoys to generate binding energy landscape
is dependent on the docking space that the ligand can explore, the grid box for ligand
docking should be sufficiently large to cover the active site as well as significant
portionsofthesurroundingsurface.Theedgesofthegridboxweresetasfivetimesas
the radius of gyration of the naive conformation of ligand to guarantee the enough
explorationoftheactivesite,andthegridboxwascenteredonthegeometriccenterof
the native pose with a grid spacing of 0.375. Within the grid box, Autodock4.2
stochastically generates a population of conformational, rotational, and translational
isomers from the starting structure of the ligand and docks them with the
conformational search method of Lamarckian genetic algorithm. During the search,
the ligand was considered conformationally flexible with its torsional bonds defined
by AutoDock4.2 according to their chemical features. For each protein-ligand
complex, 500 separate docking runs were performed which resulted in a database of
500 decoys for each complex. Other parameters were set as the default values of
AutoDock4.2.
Quantitative description of specificity and affinity. To get a potential energy
function which can maximize the binding specificity and the consistence between
predicted and experimental affinity, we rewrote the initial energy function by
introducing a set of adjustable parameters as the coefficients ck for the potentials of
atom pair, that is
E~
P
k
ckfkuk ð5Þ
where E is the total intermolecular energy of a protein-ligand complex. k stands for
the type of atom pair interaction, there are 1616 types by multiplying the number of
effective atom pairs (5101) and the number of shells (516). fk represents the
occurrences of the interaction type k between the protein and ligand, and uk is an
alternative representation of uij(r) in equation 1.
Theintrinsicspecificratio(ISR)foragivenprotein-ligand complexmiscalculated
as
lm~a dE
DE ð6Þ
where a is a scaling factor which accounts for the contribution of the entropy to the
specificity
13. Here, it approximately depends on the number of torsional bonds of the
ligands a*
ﬃﬃﬃﬃ
1
ntb
q
. dE is the energy gap between the energy of native conformation EN
and the average energy of ensemble of decoys , ED .,a n dDE is the energy fluc-
tuation or the width of the energy distribution of the decoys (Fig. 2), namely
dE~jEN{vEDwjð 7Þ
DE~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
vE2
Dw{vEDw2 p
ð8Þ
,. means the average over the ensemble of decoys. Combined equations 5–8
together, the lm can be represented as
lm~
aj
P
kckuk f N
k {vfkw ðÞ j P
k
P
lckclukul vfkflw{vfkwvflw ðÞ ð9Þ
where k,l are the indices of the interaction types. Once fk is computed for each
interaction type in the decoys, one can easily compute the value of lm for a given set
of ck.
The lm above is defined for a single protein-ligand complex, while we seek the
potential energy function that simultaneously makes lm values large enough for the
whole proteinlingand complexes in the training set. Therefore we need a single
objective function that reflects the lm values for all the protein-ligand complexes in
the training set. We chose the Bolzmann-like weighted average of lm as the objective
function which is
l~
P
mlm exp bllm ðÞ P
m exp bllm ðÞ ð10Þ
where bl is a constant value for weighting which is set as 20.1. The Bolzmann-like
weightedaveragehastheadvantageoverthenormallyusedalgebraicaveragesincethe
protein-ligand complex with the smallest absolute value of lm contribute most to the
objectivefunctionl.Ifweoptimizethesmallestvalueoflmfromthedistributionpool
among different protein-ligand binding complexes, we will be sure that even the
smallest lm will be large enough for discrimination of separating the ‘‘native’’ from
non-native decoys. Therefore Bolzmann-like weighted average is an appropriate
combination of individual lm to match our purpose that all the resulting
www.nature.com/scientificreports
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This average approach has similar function as some other weighted average
approaches used for optimizing energy function of protein folding
37–39.
The quantitative measurements of the correlation between predicted and experi-
mental affinity is depicted with Pearson’s correlation coefficient by
c~
Sm E
p
m{vE
p
mw
  
Ee
m{vEe
mw
  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sm E
p
m{vE
p
mw
   2
q ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sm Ee
m{vEe
mw
   2
q ð11Þ
The predicted binding affinity E
p
m for the protein-ligand complex is represented by
the binding scores calculated from our scoring function with a given set of ck. The
experimentally measured affinity Ee
m is expressed in log Kd or log Ki units, where Kd
and Ki are experimentally determined dissociation constant and inhibition constant
respectively for the protein-ligand complex m.
Optimization ofpotential energyfunction. Aftergettingtheinitial potentialenergy
and decoy ensembles, the energy function can be readily optimized. The aim of
optimization here is to maximize the value of l for specificity and the value of c for
affinity, a combination parameter (r 5 lc) which couples specificity and affinity is
constructed toevaluate the performance ofscoring function duringtheoptimization.
The optimization is performed by Monte Carlo (MC) search with simulated
annealinginthespaceofadjustablecoefficientsck.Theinitialvaluesofcoefficientsare
set as 1.0 here, which means optimization of the scoring function starts from the
energy function obtained through equation 1-4. A constraint is applied to ck by
restricting it varied within [1
5, 5] times of its initial value, otherwise some coefficients
couldbecomeverylargeorsmallduetoinfrequentoccurrencesoftheinteractions.At
eachMCsteponeofthe coefficients ischosenatrandom and addedwith0.2or 20.2.
The resulting change in E (E is defined as E 52 r, minimizing E is equivalent of
maximizing r) is accepted with the probability
P~min 1,exp {brDE
     
ð12Þ
where b
{1
r is the optimization temperature for r. This guarantees the chosen MC
steps statistically prefer the low E and high r. The temperature b
{1
r decreases
exponentially during the search and the starting temperature is 0.5. The search
convergeswellwithin300,000 MCsteps(SupplementaryFig.2a),whichsuggeststhat
a set of ck are found maximally optimized for r. The convergence of both l and c
(Supplementary Fig. 2b) indicates the optimized scoring function reaches the
maximal performance of simultaneously quantifying the specificity and affinity. For
eachMCsearch,1500protein-ligandcomplexesarerandomlyselectedasthetraining
set from the refined set of PDBbind database except the complexes in the test set. 5
independentMCsimulationswereperformed,andtheaverageofcorrelationbetween
thecoefficients fromdifferent MCsimulations is0.80.Thishigh correlationindicates
our optimization is successful and robust on the training set.
Validation of SPA. To validate SPA, two kinds of tests were taken. First, SPA was
tested on a benchmark of protein-ligand complexes which is a high-quality setof 195
protein-ligand complexes selected out from the refined set of 2007 version of the
PDBbind database
24. This benchmark was taken as testing set to compare the
performance for a large collection of 16 scoring functions implemented in main-
stream commercial softwares or available from academic research groups, which
offers a reference for the performance of SPA. Each protein-ligand complex of the
benchmark set was docked with the same parameter as the training set above to
generate a binding energy landscape with decoy ensemble. Second, SPA was applied
onatargetproteincyclooxygenase-2(COX-2)forthevirtualscreeningtest.COX-2is
theinhibitiontarget ofnonsteroidalanti-inflammatory drugs (NSAIDs) forreducing
fever and inflammation. A diverse set of 650 small molecules were selected from the
NCI-Diversity database
40 having molecular weights similar to that of the reference
compound SC-558, with which the crystal structure of the COX-2 complex is
available (PDB code 1CX2)
41,42. 37 COX-2 selective and 20 nonselective drugs
(Supplementary Table. 4) of NSAIDs are taken for the test of discrimination of drugs
from the diversity set, as well as the discrimination of selective from non-selective
drugs. COX-2 selective inhibitors are specific to inhibit only COX-2, while COX-2
non-selective drugs inhibit both the COX-2 and its isoenzyme COX-1. Also, each
ligandwas docked toCOX-2togenerate abindingenergy landscape with 2000 decoy
conformations,andtheboxsizeofdockingwassetas100*100*100gridscenteredat
the compound SC-558. Since the crystal structures of COX-2 with the ligands in the
diversity set are not available, by clustering the decoys the same as implemented in
AutoDocksoftware,thedecoywiththelowestenergyinthelargestpopulationcluster
was considered as the ‘‘native’’ pose
43. The evaluation methods
44 including the
enrichment test and the Kolmogorov-Smirnov test (KS test) were employed to
describe the performance of SPA for COX-2 system.
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